034940 — ChoA Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩50bn
- KR₩61bn
- KR₩63bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1,122 | -1,606 | -8,043 | 515 | -11,133 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 4,168 | 3,494 | 4,641 | 1,840 | 7,618 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,700 | -3,016 | -973 | -6,187 | -347 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4,157 | 1,922 | -1,480 | -1,443 | -1,475 |
Capital Expenditures | -1,662 | -3,641 | -3,864 | -2,922 | -943 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -709 | -396 | 1,998 | 1,369 | 1,674 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,371 | -4,037 | -1,866 | -1,553 | 731 |
Financing Cash Flow Items | -202 | -168 | 101 | 11.5 | -27.2 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2,092 | -3,832 | 4,825 | 1,807 | -1,690 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -100 | -5,873 | 1,585 | -1,223 | -2,478 |